Cargando…
Refractory venous leg ulcers: observational evaluation of innovative new technology
This observational case series reports the evaluation of a novel neuromuscular electrical stimulation device (geko™) that stimulates the common peroneal nerve at the fibular head as an adjunctive therapy in patients with non‐healing venous leg ulcers. The aim was to evaluate and determine if the gek...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949764/ https://www.ncbi.nlm.nih.gov/pubmed/28664657 http://dx.doi.org/10.1111/iwj.12766 |
_version_ | 1783663525446549504 |
---|---|
author | Harris, Connie Loney, Amanda Brooke, Jillian Charlebois, Amanda Coppola, Lucy Mehta, Sowmil Flett, Norman |
author_facet | Harris, Connie Loney, Amanda Brooke, Jillian Charlebois, Amanda Coppola, Lucy Mehta, Sowmil Flett, Norman |
author_sort | Harris, Connie |
collection | PubMed |
description | This observational case series reports the evaluation of a novel neuromuscular electrical stimulation device (geko™) that stimulates the common peroneal nerve at the fibular head as an adjunctive therapy in patients with non‐healing venous leg ulcers. The aim was to evaluate and determine if the geko™ device was effective in this population and should be added to the medical supply formulary. Patients whose wounds had failed to heal within 24 weeks of standard therapy were identified in two community settings in Ontario. A total of 11 patients consented to the evaluation with a combined 107‐year history of recalcitrant leg ulcers. Although the pre‐geko™ healing rate was unknown, all ulcers were considered non‐healing. With geko™, the average weekly percentage reduction in surface area for all patients was 4·5% and for the six adherent to geko™ and best practices 7·0%. By comparison, the average weekly percentage reduction for measurable wounds in the five non‐adherent patients was 1·8%. Requirements for success appear to include an arterial status adequate for healing, effective and prompt management of wound infections and adherence to the treatment schedule. The geko™ device has been added to the medical supply formulary in one centre and is pending in the other. |
format | Online Article Text |
id | pubmed-7949764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-79497642021-07-02 Refractory venous leg ulcers: observational evaluation of innovative new technology Harris, Connie Loney, Amanda Brooke, Jillian Charlebois, Amanda Coppola, Lucy Mehta, Sowmil Flett, Norman Int Wound J Original Articles This observational case series reports the evaluation of a novel neuromuscular electrical stimulation device (geko™) that stimulates the common peroneal nerve at the fibular head as an adjunctive therapy in patients with non‐healing venous leg ulcers. The aim was to evaluate and determine if the geko™ device was effective in this population and should be added to the medical supply formulary. Patients whose wounds had failed to heal within 24 weeks of standard therapy were identified in two community settings in Ontario. A total of 11 patients consented to the evaluation with a combined 107‐year history of recalcitrant leg ulcers. Although the pre‐geko™ healing rate was unknown, all ulcers were considered non‐healing. With geko™, the average weekly percentage reduction in surface area for all patients was 4·5% and for the six adherent to geko™ and best practices 7·0%. By comparison, the average weekly percentage reduction for measurable wounds in the five non‐adherent patients was 1·8%. Requirements for success appear to include an arterial status adequate for healing, effective and prompt management of wound infections and adherence to the treatment schedule. The geko™ device has been added to the medical supply formulary in one centre and is pending in the other. Blackwell Publishing Ltd 2017-06-30 /pmc/articles/PMC7949764/ /pubmed/28664657 http://dx.doi.org/10.1111/iwj.12766 Text en © 2017 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Harris, Connie Loney, Amanda Brooke, Jillian Charlebois, Amanda Coppola, Lucy Mehta, Sowmil Flett, Norman Refractory venous leg ulcers: observational evaluation of innovative new technology |
title | Refractory venous leg ulcers: observational evaluation of innovative new technology |
title_full | Refractory venous leg ulcers: observational evaluation of innovative new technology |
title_fullStr | Refractory venous leg ulcers: observational evaluation of innovative new technology |
title_full_unstemmed | Refractory venous leg ulcers: observational evaluation of innovative new technology |
title_short | Refractory venous leg ulcers: observational evaluation of innovative new technology |
title_sort | refractory venous leg ulcers: observational evaluation of innovative new technology |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949764/ https://www.ncbi.nlm.nih.gov/pubmed/28664657 http://dx.doi.org/10.1111/iwj.12766 |
work_keys_str_mv | AT harrisconnie refractoryvenouslegulcersobservationalevaluationofinnovativenewtechnology AT loneyamanda refractoryvenouslegulcersobservationalevaluationofinnovativenewtechnology AT brookejillian refractoryvenouslegulcersobservationalevaluationofinnovativenewtechnology AT charleboisamanda refractoryvenouslegulcersobservationalevaluationofinnovativenewtechnology AT coppolalucy refractoryvenouslegulcersobservationalevaluationofinnovativenewtechnology AT mehtasowmil refractoryvenouslegulcersobservationalevaluationofinnovativenewtechnology AT flettnorman refractoryvenouslegulcersobservationalevaluationofinnovativenewtechnology |